Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Clinical trial NCT01214837 · COMPLETED

Trial details

NCT number: NCT01214837
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Disease Meningococcal Meningitis

Start date: 2010-10-01
Primary completion: 2012-04-01
Enrollment: 751

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.